tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Neurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment
Company AnnouncementsNeurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment
11d ago
Neurizon Therapeutics Secures Global Licensing Agreement with Elanco
PremiumCompany Announcements
Neurizon Therapeutics Secures Global Licensing Agreement with Elanco
19d ago
Neurizon Therapeutics Announces Licensing Agreement and Upcoming Shareholder Webinar
PremiumCompany Announcements
Neurizon Therapeutics Announces Licensing Agreement and Upcoming Shareholder Webinar
19d ago
Neurizon Therapeutics Secures Global License with Elanco to Advance Neurodegenerative Treatment
PremiumCompany Announcements
Neurizon Therapeutics Secures Global License with Elanco to Advance Neurodegenerative Treatment
19d ago
Neurizon Therapeutics Issues Unquoted Equity Securities
PremiumCompany Announcements
Neurizon Therapeutics Issues Unquoted Equity Securities
25d ago
Neurizon Therapeutics Unveils Liquid Formulation of NUZ-001 for ALS
PremiumCompany AnnouncementsNeurizon Therapeutics Unveils Liquid Formulation of NUZ-001 for ALS
25d ago
Neurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
Premium
Company Announcements
Neurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
1M ago
Neurizon Therapeutics to Release Shares from Escrow
Premium
Company Announcements
Neurizon Therapeutics to Release Shares from Escrow
1M ago
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
PremiumCompany Announcements
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
2M ago
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
PremiumCompany Announcements
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
2M ago
Neurizon Therapeutics to Present Q3 FY2025 Results and Progress on ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics to Present Q3 FY2025 Results and Progress on ALS Treatment
3M ago
Neurizon Therapeutics Reports Promising Results from NUZ-001 ALS Study
PremiumCompany Announcements
Neurizon Therapeutics Reports Promising Results from NUZ-001 ALS Study
3M ago
Neurizon Therapeutics Advances ALS Drug Development with Key Milestones
PremiumCompany AnnouncementsNeurizon Therapeutics Advances ALS Drug Development with Key Milestones
3M ago
Neurizon Therapeutics Announces Quarterly Shareholder Update Webinar
Premium
Company Announcements
Neurizon Therapeutics Announces Quarterly Shareholder Update Webinar
3M ago
Neurizon Therapeutics Strengthens Leadership with New CFO Appointment
Premium
Company Announcements
Neurizon Therapeutics Strengthens Leadership with New CFO Appointment
3M ago
Neurizon Therapeutics Bolsters Leadership Team with Strategic Appointments
PremiumCompany Announcements
Neurizon Therapeutics Bolsters Leadership Team with Strategic Appointments
3M ago
Neurizon Therapeutics Reports Promising Study Results on NUZ-001
PremiumCompany Announcements
Neurizon Therapeutics Reports Promising Study Results on NUZ-001
4M ago
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
PremiumCompany Announcements
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
4M ago
Neurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
PremiumCompany Announcements
Neurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
4M ago
Neurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
PremiumCompany AnnouncementsNeurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
4M ago
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
Premium
Company Announcements
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
5M ago
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
Premium
Company Announcements
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >